SCHEMBL995740

SCHEMBL995740

CC(=O)OC(C)CC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27658634 0.81
SCHEMBL19418189 0.79
SCHEMBL27804616 0.79
SCHEMBL6291341 0.79
SCHEMBL1921339 0.79
SCHEMBL30042216 0.79 MGAM (0.43)
SCHEMBL13242077 0.79 TSHR (0.44)
SCHEMBL10525623 0.78 TSHR (0.42)
SCHEMBL15722793 0.77 TSHR (0.42)
SCHEMBL9451858 0.77 MEN1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112225645-B Preparation method of m-cresol 万华化学集团股份有限公司 2022-08-05 CN claimed
CN-112225645-A Preparation method of m-cresol 万华化学集团股份有限公司 2021-01-15 CN claimed
US-20130059320-A1 Selective growth media for campylobacter bacteria and plating media with said growth media RESTAINO LAWRENCE (US) 2013-03-07 US claimed
US-20230029301-A1 SCALEABLE PREPARATION OF POLYKETIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-01-26 US disclosed
CN-112225645-B Preparation method of m-cresol 万华化学集团股份有限公司 2022-08-05 CN disclosed
EP-4009966-A1 SCALEABLE PREPARATION OF POLYKETIDES The Regents of the University of California (US) 2022-06-15 EP disclosed
WO-2021026273-A1 SCALEABLE PREPARATION OF POLYKETIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-02-11 WO disclosed
CN-112225645-A Preparation method of m-cresol 万华化学集团股份有限公司 2021-01-15 CN disclosed
EP-2635640-B1 NOVEL APPLICATIONS OF INDOLOINDOLE AND INDOLOQUINOLINE DYES BIOSYNTH AG (CH) 2019-07-10 EP disclosed
US-9718052-B2 Catalysts and related processes for producing optically pure beta-lactones from aldehydes and compositions produced thereby THE UNIVERSITY OF TOLEDO (US) 2017-08-01 US disclosed
US-20170021343-A1 Catalysts and Related Processes For Producing Optically Pure Beta-Lactones From Aldehydes and Compositions Produced Thereby THE UNIVERSITY OF TOLEDO (US) 2017-01-26 US disclosed
EP-0714897-B1 FUSED HETEROAROMATIC CYCLOPENTENE DERIVATIVE HAVING ENDOTHELIN-ANTAGONIST ACTIVITY BANYU PHARMA CO LTD (JP) 2001-02-14 EP disclosed
EP-0906108-A4 METHOD OF TREATING HEART FAILURE WITH ENDOTHELIN ANTAGONISTS BANYU PHARMA CO LTD (JP) 2000-12-06 EP disclosed
US-6087360-A TREATING PATIENTS WITH ENDOTHELIN RELATED DISORDERS BANYU PHARMACEUTICAL CO., LTD. (JP) 2000-07-11 US disclosed
EP-0906108-A1 METHOD OF TREATING HEART FAILURE WITH ENDOTHELIN ANTAGONISTS BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-04-07 EP disclosed
US-5834483-A Method of treating heart failure with endothelin antagonists MERCK & CO., INC. (US) 1998-11-10 US disclosed
US-5714479-A TREATMENT OF HYPERTENSION, ACUTE RENAL FAILURE, ANGINA PECTORIS, ARTERIOSCLEROSIS, ASTHMA, GASTRIC ULCER AND SIMILAR AILMENTS BANYU PHARMACEUTICAL CO., LTD. (JP) 1998-02-03 US disclosed
WO-1997037665-A1 METHOD OF TREATING HEART FAILURE WITH ENDOTHELIN ANTAGONISTS BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-10-16 WO disclosed
EP-0714897-A1 FUSED HETEROAROMATIC CYCLOPENTENE DERIVATIVE HAVING ENDOTHELIN-ANTAGONIST ACTIVITY BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-06-05 EP disclosed
US-4128728-A Production of 2,3,6-trimethylphenol BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DE) 1978-12-05 US disclosed